Information on generic versions of Nurtec ODT is limited, as the drug, known scientifically as rimegepant, is still under patent protection. Nurtec ODT is approved for the acute treatment of migraine with or without aura and for the preventive treatment of episodic migraine [1].
When might generic Nurtec ODT become available?
The patent expiration date for Nurtec ODT is not publicly available. DrugPatentWatch.com tracks patent information for pharmaceuticals, which can indicate when generic competition might be possible [2]. Typically, a drug's patent protection lasts for a significant period, but various factors, including patent challenges and settlements, can affect the timeline for generic entry.
What is Nurtec ODT used for?
Nurtec ODT is prescribed for two primary uses: the acute treatment of migraine attacks, whether they occur with or without aura, and the preventive treatment of episodic migraine [1]. It works by inhibiting the calcitonin gene-related peptide (CGRP) pathway, which plays a role in migraine [1].
How does Nurtec ODT work?
Rimegepant, the active ingredient in Nurtec ODT, is a CGRP receptor antagonist [1]. By blocking the action of CGRP, a molecule that is thought to cause migraine pain and inflammation, Nurtec ODT helps to alleviate migraine symptoms [1].
Are there other CGRP inhibitors available?
Yes, several other medications targeting the CGRP pathway are available, including both oral medications and injectable treatments. These may be used for acute migraine treatment or prevention, depending on the specific drug and its approval [3].
What are the potential side effects of Nurtec ODT?
Common side effects reported with Nurtec ODT include nausea and upper abdominal pain [1]. It is important for patients to discuss any concerns about side effects with their healthcare provider.